Nasdaq's Hearing Panel denied Aditxt, Inc.'s request to maintain its listing, resulting in the suspension of common stock trading effective at the market open on June 25, 2026. The delisting follows non-compliance with the minimum $1.00 bid price rule and a failure to meet the $2,500,000 minimum stockholders' equity requirement, as the company reported $(35,174,386) in stockholders' equity for the period ended March 31, 2026. The company is ineligible for a compliance period due to previous significant reverse stock splits. Aditxt may request a review by the Nasdaq Listing and Hearing Review Council within 15 days. Aditxt, Inc. is a healthcare technology company.
